mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |